When novel formulations of glucagon emerged onto the market by 2019, including intranasal and premixed liquids, their wholesale acquisition costs per kit started just below the cost of unmixed ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat ...

Two easy-to-use new glucagon rescue products, an autoinjector pen and a prefilled syringe, have been approved in the US for use in severe hypoglycemia in diabetes patients aged 2 years and older.

Among such instances where glucagon was administered, the average response time to calls for emergency medical services was 15.34 minutes (SD 11.50). Of these, only 3,944 patients reported having ...

Glucagon for injection, 1 mg/vial, had a market value of roughly $124 million, per IQVIA May 2025 data. [Read more: Lupin launches generic Atrovent Nasal Spray] ...

The US Food and Drug Administration has approved the first-ever generic glucagon injection kit for the treatment of severe hypoglycemia in patients with diabetes and as a diagnostic aid. The FDA ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Applications for liraglutide ...